Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10253)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
TRIM46
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4) [Suppressor]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Retinopathy | ICD-11: 9B71 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Ubiquitin mediated proteolysis | hsa04120 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
HRCECs (Human retinal capillary endothelial cells) | |||
Response regulation | TRIM46 interacted with GPX4, an important enzyme that suppresses ferroptosis, and promoted GPX4 ubiquitination. The role of TRIM46 in GPX4 ubiquitination should inspire the future development of new therapies against diabetic retinopathy (DR). | |||
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [2] | |||
Responsed Disease | Retinopathy | ICD-11: 9B71 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Ubiquitin mediated proteolysis | hsa04120 | |||
NF-kappa B signaling pathway | hsa04064 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
HRCECs (Human retinal capillary endothelial cells) | |||
Response regulation | Diabetic retinopathy (DR) as a severe diabetic complication contributes to blindness. TRIM46 interacts with IB to activate the NF-B signaling pathway, thereby enhancing cell proliferation inhibition, hyper permeability and the inflammatory response of HRCECs in a HG state. | |||
Retinopathy [ICD-11: 9B71]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | Tripartite motif-containing protein 46 (TRIM46) | Protein coding | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Ubiquitin mediated proteolysis | hsa04120 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
HRCECs (Human retinal capillary endothelial cells) | |||
Response regulation | TRIM46 interacted with GPX4, an important enzyme that suppresses ferroptosis, and promoted GPX4 ubiquitination. The role of TRIM46 in GPX4 ubiquitination should inspire the future development of new therapies against diabetic retinopathy (DR). | |||
Experiment 2 Reporting the Ferroptosis-centered Disease Response | [2] | |||
Target Regulator | Tripartite motif-containing protein 46 (TRIM46) | Protein coding | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Ubiquitin mediated proteolysis | hsa04120 | |||
NF-kappa B signaling pathway | hsa04064 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
HRCECs (Human retinal capillary endothelial cells) | |||
Response regulation | Diabetic retinopathy (DR) as a severe diabetic complication contributes to blindness. TRIM46 interacts with IB to activate the NF-B signaling pathway, thereby enhancing cell proliferation inhibition, hyper permeability and the inflammatory response of HRCECs in a HG state. | |||
References